Загрузка...
Tumor Lysis Syndrome in Patients with Hematological Malignancies
Tumor lysis syndrome is a metabolic complication that may follow the initiation of cancer therapy. It commonly occurs in hematological malignant patients particularly non-Hodgkin's lymphoma and acute leukemia due to chemotherapy or spontaneously. It is characterized by a biochemical abnormality...
Сохранить в:
| Опубликовано в: : | J Oncol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5688348/ https://ncbi.nlm.nih.gov/pubmed/29230244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/9684909 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|